Your source of breaking information about Dutasteride also known as Avodart, Avolve, GI198745, GG745 or Duagen.
dutasteride duagen avodart avolve is an independent clearinghouse for information about Dutasteride and is not associated or affiliated with GlaxoSmithKline or the Glaxo Group Limited. Avolve, Avodart and Duagen are registered trademarks of Glaxo Group Limited.  

What is Dutasteride

The Latest News

Dutasteride Studies

Dutasteride Safety Profile

FDA Approval Documents

Dutasteride Results

If you are interested in getting more information via email about the availability of Avodart please enter your email address below

hair loss MPB Dutasteridedutastiride avolve duagen
Nov 22, 2002 - Dutasteride is available now in pharmacies in the US - Source:
Nov 11, 2002 - Glaxo cancels Phase 3 hair loss trials for Dutasteride - Source:
Oct 22, 2002 - Glaxo set to conduct Phase 3 hair loss trials for Dutasteride in February or March, 2003 in the US. Sites have already been selected for the trials - Source:
Oct 10, 2002 - FDA Approves Dutasteride sNDA - Source:
July 25, 2002 - Dutasteride is approved in Sweden for BPH - Source:

Listen to the Bald Truth Radio show from November 27, 1999. Dr Marty Sawaya was the guest and the first person to talk about Dutasteride on Spencer Kobren's show. [Requires RealAudio Player]

lowers DHT and promotes hair regrowth
Glaxo sells Avodart also know as Dutasteride   Avolve Avodart  GI198745  Duagen
  Copyright © 2002 Interactive Marketing Group - All Rights Reserved - email: [email protected]